This has been expected news all along, but the Associated Press reported last night that prosecutors plan to have Andy Pettitte testify in the Roger Clemens perjury trial, which is set to begin jury selection on April 16.
The government says Pettitte will testify about his use of human growth hormone with the assistance of Brian McNamee, Clemens’ former trainer. Pettitte has previously acknowledged that McNamee injected him twice with HGH while he was recovering from an injury.
Pettitte came out of retirement last week and signed a one-year, $2.5 million minor league contract with the Yankees. The current timeline has the 39-year-old southpaw being major-league ready by around May 1, so the trial shouldn’t have a big impact on his status.
Astros’ star second baseman José Altuve underwent surgery on his right knee, MLB.com’s Brian McTaggart reports. Neither the specifics of the surgery nor a concrete timetable for the infielder’s recovery have been officially confirmed by the club yet.
Altuve, 28, suffered the injury in July after he jammed his knee on a close play at third base. Even after he completed an initial 3.5-week stint on the 10-day disabled list, chronic knee pain continued to dog him in the months that followed. As manager A.J. Hinch told reporters on Thursday, he would have held the second baseman out of the lineup under any other circumstances, but instead chose to commend Altuve for showing up and pushing through the pain as the Astros tried for a repeat championship title this postseason.
Per McTaggart, the Astros expect Altuve to make a full recovery by spring. The perennial All-Star infielder finished his 2018 run with a .316/.386/.451 batting line, 13 home runs, and an .837 OPS through 599 plate appearances. He fared slightly worse during Houston’s ALDS and ALCS campaigns, slashing .265/.324/.412 with three extra-base hits over 37 PA. The Astros were eliminated by the Red Sox during Thursday’s 4-1 loss in ALCS Game 5.